89bio Inc (ETNB) Event May 12, 2022, 00:00 UTC (61% Neutral) 89bio, Inc. (ETNB) Reports Net Loss for 2022-03-31 Full text
Register to leave comments News bot Oct. 29, 2025, 8:54 a.m. 🏢 89bio Inc (ETNB) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-05-12 📊 Period of Report: 2022-03-31 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-14.78M $-14.78M N/A +0.00% ➡️ Total Assets $162.42M $135.76M $26.66M +19.63% 📈 Total Liabilities $36.47M $33.02M $3.44M +10.42% 📉 Stockholders' Equity $190.19M $-137.88M $328.07M +237.95% 📈 Operating Income/Loss $-14.74M $-25.11M $10.37M +41.30% 📉 R&D Expense $10.13M $19.85M $-9.72M -48.96% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 89bio Inc (ETNB) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document